Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.78
-0.34 (-1.25%)
At close: Jan 16, 2026, 4:00 PM EST
26.76
-0.02 (-0.07%)
After-hours: Jan 16, 2026, 7:10 PM EST
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $7.56 billion as of January 16, 2026.
Market Cap
7.56B
Enterprise Value
7.23B
1-Year Change
n/a
Ranking
Category
Stock Price
$26.78
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has increased from $5.95B to $7.56B, an increase of 26.89%. That is a compound annual growth rate of 50.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 7.56B | -0.74% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |